Dexiang Liu
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Combining network pharmacology, machine learning, molecular docking, molecular simulation dynamics and experimental validation to explore the mechanism of Zhenwu decoction in treating major depression through TNF-α pathways.
Journal: Behavioural brain research
Published: August 08, 2025
The effects of hippocampal miR-34c-5p on the age-related discrepancies in susceptibility to traumatic stress in the post-traumatic stress disorder mice model.
Journal: Molecular pharmacology
Published: June 05, 2025
Liposomes-loaded miR-128-3p exert neuroprotective effects in hypoxia-ischemia injury by targeting Rgs1 in neonatal mice.
Journal: European journal of pharmacology
Published: May 09, 2025
Liposome-loaded miR-34c-5p attenuates apoptosis and oxidative stress following hypoxia-ischemia brain damage in neonatal mice by targeting Arhgap26.
Journal: European journal of pharmacology
Published: December 05, 2024
Aberrant neuronal excitation promotes neuroinflammation in the primary motor cortex of ischemic stroke mice.
Journal: Acta pharmacologica Sinica
Published: August 09, 2024
Engineered Extracellular Vesicles Loaded with MiR-100-5p Antagonist Selectively Target the Lesioned Region to Promote Recovery from Brain Damage.
Journal: Neuroscience bulletin
Published: May 11, 2024
Programmed cell death factor 4-mediated hippocampal synaptic plasticity is involved in early life stress and susceptibility to depression.
Journal: Behavioural brain research
Published: February 22, 2024
Early life stress enhances the susceptibility to depression and interferes with neuroplasticity in the hippocampus of adolescent mice via regulating miR-34c-5p/SYT1 axis.
Journal: Journal of psychiatric research
Published: September 02, 2023
Mitochondria-targeted cerium vanadate nanozyme suppressed hypoxia-ischemia injury in neonatal mice via intranasal administration.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 16, 2023
Rifaximin ameliorates depression-like behaviour in chronic unpredictable mild stress rats by regulating intestinal microbiota and hippocampal tryptophan metabolism.
Journal: Journal of affective disorders
Published: October 07, 2022
Last Updated: 09/26/2026